ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -37.5% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8 | +33.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6 | -99.9% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | -12.5% | 200 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $8,000 | -11.1% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $9,000 | -30.8% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | +8.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $12,000 | -58.6% | 200 | -42.9% | 0.00% | -60.0% |
| Q2 2021 | $29,000 | +26.1% | 350 | 0.0% | 0.01% | +25.0% |
| Q1 2021 | $23,000 | -57.4% | 350 | -50.0% | 0.00% | -63.6% |
| Q4 2020 | $54,000 | +80.0% | 700 | 0.0% | 0.01% | +57.1% |
| Q3 2020 | $30,000 | 0.0% | 700 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $30,000 | +50.0% | 700 | 0.0% | 0.01% | +16.7% |
| Q1 2020 | $20,000 | -68.3% | 700 | -30.0% | 0.01% | -62.5% |
| Q4 2019 | $63,000 | +125.0% | 1,000 | 0.0% | 0.02% | +100.0% |
| Q3 2019 | $28,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |